Traitomic raises €20M Series A to find crop traits without gene editing
Carlsberg spinout Traitomic closed a €20M Series A led by Sofinnova to sell crop and microbe traits found without gene editing, with the US and Australia next.
Also see more funding coverage: /funding/
Denmark
Copenhagen-based Traitomic raised a €20M Series A on November 17, led by Sofinnova Partners, to scale FIND-IT, its platform for finding useful crop and microbe traits without gene editing.
Sofinnova leads the first outside money into a Carlsberg spinout
Traitomic announced the round on November 17, 2026, according to HortiDaily. Sofinnova Partners led. The Export and Investment Fund of Denmark (EIFO), Footprint Firm, Nordic Foodtech VC, PSV Hafnium and SVG Ventures joined. AgFunderNews reports the amount as $22M. It is the company’s first external investment since the spinout from Carlsberg.
Get the Weekly brief
The week’s rounds, last calls and events, every Monday.
The money goes to international expansion, starting with the US and Australia, where Traitomic has had a small presence for a couple of years and now plans local hiring. It also funds more risk-taking with customers, including new areas such as algae and mushrooms. CEO and co-founder Gustav Hambraeus told AgFunderNews the raise is “all about commercial scaling and really getting out there.”
116 traits for 47 customers, from a brewer’s lab
FIND-IT was developed at the Carlsberg Research Laboratory to improve barley for brewing. Traitomic no longer works with barley or brewers. The platform identifies genetic variants in conventionally bred populations without editing an organism’s DNA, so a variant linked to, say, sugar content in tomatoes becomes the starting point for a customer’s own breeding program. Because the trait involves no gene editing, it can be sold as a conventional product.
The company reports 116 traits delivered to 47 customers across 32 organisms, from plant breeding and seed to precision nutrition and industrial biotech. AgNavigator lists lupin, pea, bean, oat and canola among the crops, a quinoa trait delivered in under 10 months, and four to eight weeks from identification to handover on established platforms. Hambraeus is direct about the competition: “Gene editing can be an excellent option in some situations, and FIND-IT is not intended to replace it.” Anders Røed, Carlsberg’s EVP for group strategy and commercial, said fundamental research “can create value far beyond its original field of application.” The full profile sits on the Traitomic startup page.
An $8.91bn breeding market and two Series A yardsticks
MarketsandMarkets, in a March 2025 release, sized plant breeding and CRISPR plants at $8.91bn in 2025, growing to $13.86bn by 2030, a 9.2% compound annual growth rate. That segment bundles conventional breeding with gene-edited crops, and no reliable sizing exists for trait discovery services alone. Traitomic positions FIND-IT as an alternative route to gene editing, aimed at customers who want precision inside a conventional development path.
Our own database gives the check a scale. Zymofix, a Deinze-based startup in the same crop biotech tag, closed a Series A recorded at €6M on October 2, so Traitomic’s round is more than three times larger. RED Horticulture’s €17M Series A from November 2023 is the closer match, and Traitomic sits about 18% above it.
Patient science finds patient money
The hard fact is that trait work lives on long clocks. AgNavigator reports that many plant traits are still moving through customers’ development pipelines, while some microbial applications have already reached commercial products because their cycles are shorter. A Series A led by a life-sciences specialist, with a Danish state fund and a Nordic food-tech fund beside it, shows capital that is willing to wait for those cycles at home. The other European rounds we track show how that backing compares.
What to watch is the first US and Australian customer announcements, and the date a plant trait from FIND-IT reaches a commercial variety. Imagine if the next European crop trait came from a brewer’s laboratory in Copenhagen and reached fields on three continents. The opportunity is clear.